Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Revenues:
Total revenues	$ 228,640	$ 214,824	$ 416,703	$ 362,417
Cost of revenues	(193,304)	(204,317)	(285,517)	(326,677)
Gross profit	35,336	10,507	131,186	35,740
Operating expenses:
Research and development	2,047,839	1,936,608	3,794,607	3,246,130
General and administrative	1,382,793	1,062,558	3,924,261	2,011,876
Total operating expenses	3,430,632	2,999,166	7,718,868	5,258,006
Loss from operations	(3,395,296)	(2,988,659)	(7,587,682)	(5,222,266)
Other income (expense):
Gain on forgiveness of PPP loan		421,584		421,584
Foreign currency transaction (loss)/gain	94,900	17,330	(13,393)	44,583
Interest expense, net	(214,908)	(235,736)	(426,622)	(449,241)
Research and development incentives	(26,391)	23,671	136,981	81,052
Total other income (expense)	(146,399)	226,849	(303,034)	97,978
Net loss before income taxes	(3,541,695)	(2,761,810)	(7,890,716)	(5,124,288)
Income tax benefit	1,154,935	864,742	1,154,935	864,742
Net loss applicable to common stockholders	$ (2,386,760)	$ (1,897,068)	$ (6,735,781)	$ (4,259,546)
Basic net loss per share (in Dollars per share)	$ (0.06)	$ (0.05)	$ (0.16)	$ (0.11)
Diluted net loss per share (in Dollars per share)	$ (0.06)	$ (0.05)	$ (0.16)	$ (0.11)
Basic weighted average common shares outstanding (in Shares)	43,012,206	40,074,275	42,966,378	38,455,210
Diluted weighted average common shares outstanding (in Shares)	43,012,206	40,074,275	42,966,378	38,455,210
Licensing revenue
Revenues:
Revenues			$ 50,000
Contract revenue
Revenues:
Other revenue				$ 33,351
Grant revenue
Revenues:
Other revenue	$ 228,640	$ 214,824	$ 366,703	$ 329,066